Dumfries & Galloway Health Board
Prescribing Support Team

Buspirone Review

Posted: 3 Aug 11 Edited: 14 Aug 18
Audits Central Nervous System

Buspirone is licensed for the short-term management of anxiety disorders and the relief of symptoms of anxiety with or without accompanying depression.

Studies have shown that the effectiveness of the drug is limited and therefore its use in the treatment of anxiety is not endorsed by NICE or any other national guideline.This protocol details a review process.